Chenglai Dong

815 total citations · 1 hit paper
10 papers, 482 citations indexed

About

Chenglai Dong is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Chenglai Dong has authored 10 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Chenglai Dong's work include RNA modifications and cancer (6 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (3 papers). Chenglai Dong is often cited by papers focused on RNA modifications and cancer (6 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (3 papers). Chenglai Dong collaborates with scholars based in China. Chenglai Dong's co-authors include Yongxin Zhou, Shaorui Gu, Zhenchuan Liu, Kaiqing Wu, Yunlang She, Lei Li, Tingting Wang, Chang Chen, Tiancheng Lu and Wenli Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cancer and Cell Cycle.

In The Last Decade

Chenglai Dong

10 papers receiving 479 citations

Hit Papers

N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-c... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer
    2021 267 citations Zhenchuan Liu, Tingting Wang et al. Molecular Cancer profile →

Peers

Chenglai Dong
Shaorui Gu China
Kaiqing Wu China
Xufan Li China
Shumei Liang China
Shijia Yan China
Zhixiang Jian China
Jiangnan Qiu China
Xiaozhi Lv China
Jianmin Wu China
Shaorui Gu China
Chenglai Dong
Citations per year, relative to Chenglai Dong Chenglai Dong (= 1×) peers Shaorui Gu

Countries citing papers authored by Chenglai Dong

Since Specialization
Citations

This map shows the geographic impact of Chenglai Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenglai Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenglai Dong more than expected).

Fields of papers citing papers by Chenglai Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenglai Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenglai Dong. The network helps show where Chenglai Dong may publish in the future.

Co-authorship network of co-authors of Chenglai Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Chenglai Dong. A scholar is included among the top collaborators of Chenglai Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenglai Dong. Chenglai Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Li, Lei, Yan Gao, Zhenchuan Liu, et al.. (2022). GDF11 alleviates neointimal hyperplasia in a rat model of artery injury by regulating endothelial NLRP3 inflammasome activation and rapid re-endothelialization. Journal of Translational Medicine. 20(1). 28–28. 11 indexed citations
2.
Dong, Chenglai, et al.. (2022). PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma. Cell Cycle. 21(13). 1406–1421. 16 indexed citations
3.
4.
Gu, Shaorui, Tiancheng Lu, Chenglai Dong, et al.. (2022). Feasibility evaluation of the transapical saddle‐shaped valved stent for transcatheter mitral valve implantation. Journal of Cardiac Surgery. 37(6). 1537–1543. 1 indexed citations
5.
Guo, Cheng, Chenglai Dong, Rui Wang, et al.. (2021). An Immune Signature Robustly Predicts Clinical Deterioration for Hepatitis C Virus-Related Early-Stage Cirrhosis Patients. Frontiers in Medicine. 8. 716869–716869. 2 indexed citations
6.
Liu, Zhenchuan, Tingting Wang, Yunlang She, et al.. (2021). N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Molecular Cancer. 20(1). 105–105. 267 indexed citations breakdown →
7.
Liu, Zhenchuan, et al.. (2021). CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation. Journal of Experimental & Clinical Cancer Research. 40(1). 361–361. 43 indexed citations
8.
9.
Huang, Haitao, Shaorui Gu, Zhenchuan Liu, et al.. (2020). Long Noncoding RNA FAM225A Promotes Esophageal Squamous Cell Carcinoma Development and Progression via Sponging MicroRNA-197-5p and Upregulating NONO. Journal of Cancer. 12(4). 1073–1084. 10 indexed citations
10.
Liu, Zhenchuan, Shaorui Gu, Tiancheng Lu, et al.. (2020). IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress. Journal of Experimental & Clinical Cancer Research. 39(1). 144–144. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaorui Gu Breakdown of academic impact, for papers by Kaiqing Wu Breakdown of academic impact, for papers by Xufan Li Breakdown of academic impact, for papers by Shumei Liang Breakdown of academic impact, for papers by Shijia Yan Breakdown of academic impact, for papers by Zhixiang Jian Breakdown of academic impact, for papers by Jiangnan Qiu Breakdown of academic impact, for papers by Xiaozhi Lv Breakdown of academic impact, for papers by Jianmin Wu
Rankless by CCL
2026